1
TABLE 2. Data of IR and H NMR Spectroscopy of the Synthesized
Compounds
Com-
pound
IR spectrum,
1Н NMR spectrum, δ, ppm ( J, Hz)
ν, cm-1
4a
3330, 3000, 1675,
1620, 1600, 1560,
1540, 1470, 1450,
1390, 1370
2.85 (3Н, d, J = 3.6, NНCH3); 7.48 (1Н, m, НAr);
7.63-7.69 (6Н, m, НAr); 7.84 (1Н, m, НAr); 8.68 (1Н, s, Н-4);
8.70 (1Н, m, НAr); 9.00 (1Н, br. s, NНCH3); 13.71 (1Н, s, NHHet
)
4b
3330, 3000, 1685,
1610, 1560, 1470,
1440, 1390, 1370,
1340, 1320, 1260,
1230
1.16 (3Н, t, J = 6.3, NНCH2CH3); 3.36 (2Н, m, NНCH2CH3);
7.49 (1Н, m, НAr); 7.62-7.76 (6Н, m, НAr);
7.88 (1Н, m, НAr); 8.69 (1Н, s, Н-4); 8.71 (1Н, m, НAr);
9.11 (1Н, br. s, NНEt); 13.73 (1Н, s, NHHet
)
4c
4d
5
3350, 3000, 1670,
1615, 1560, 1490,
1460, 1420, 1380,
1330
2.87 (3Н, d, J = 2.7, NНCH3); 7.66 (7Н, m, НAr);
8.23 (1Н, m, НHet-7); 8.74 (1Н, s, Н-4); 9.02 (1Н, br. s, NНCH3);
9.20 (1Н, m, HHet-4)
3300, 3000, 1690,
1620, 1570, 1500,
1470, 1385, 1310,
1250
1.18 (3Н, t, J = 6.6, NНCH2CH3); 3.34 (2Н, m, NНCH2CH3);
7.68-7.83 (7Н, m, НAr); 8.26 (1Н, m, НHet-7); 8.78 (1Н, s, Н-4);
9.15 (1Н, br. s, NНEt); 9.24 (1Н, m, HHet-4)
3250, 3000, 2950,
1690, 1670, 1620,
1560, 1540, 1490,
1460, 1390
2.28 (3Н, s, CH3CO); 3.16 (3Н, c, NCH3); 7.51 (1H, m, НAr);
7.55-7.72 (6Н, m, НAr); 7.87 (1Н, m, НAr); 8.18 (1Н, s, Н-4);
8.70 (1Н, m, НHet-4); 13.78 (1Н, s, NHHet
)
7a
7b
8a
3380, 3300, 3050,
2970, 1680, 1640,
1600, 1580, 1500
2.75 (3Н, d, J = 4.2, NНCH3); 3.91 (2H, m, 5'-СН2);
4.14 (2H, t, J = 9.3, 4'-СН2); 7.52 (5Н, m, C6H5);
8.31 (1Н, s, Н-4); 8.90 (1Н, br. s, NНCH3);
9.39 (1Н, br. s, NHHet
)
3400, 3300, 3100,
3000, 1680, 1640,
1610, 1580, 1500,
1450, 1380, 1330
1.08 (3Н, t, J = 7.2, NНCH2CH3); 3.21 (2Н, m, NНCH2CH3);
3.92 (2H, m, 5'-СН2); 4.13 (2H, t, J = 9.0, 4'-СН2);
7.52 (5Н, m, C6H5); 8.32 (1Н, s, Н-4); 9.02 (1Н, br. s, NНEt);
9.37 (1Н, br. s, NHHet
)
3100, 3000, 1730,
1680, 1600, 1530,
1460, 1400, 1380,
1310
1.24 (3Н, t, J = 6.9, ОСН2СН3); 3.29 (3Н, s, NCH3);
4.19 (2Н, q, J = 6.9, ОСН2СН3); 7.56-7.67 (5Н, m, C6H5);
8.18 (1Н, s, Н-4)
(or benzothiazole, 4,5-dihydro-1H-imidazole) substituent in position 5 of the heterocyclic ring have not been
described up to now, which enables us to designate the recyclization investigated by us as new, and as a method
of preparative value for the synthesis of previously unknown compounds. In fact the given reaction is a
retrorecyclization involving conversion of 2H-2-pyranone into 2-oxo-1,2-dihydropyridines occurring under the
action of ammonia and methylamine, respectively, into the methyl ester of coumalic acid [8] and 3,4,6-
triphenyl-2H-2-pyranone [9].
EXPERIMENTAL
The 1H and 13C NMR spectra were recorded on a Varian-300 instrument (300 and 75 MHz respectively)
in DMSO-d6, internal standard was TMS. The IR spectra were recorded on a UR 20 instrument in KBr disks.
5-Benzoyl-3-ethoxycarbonyl-1-methyl-6-phenylamino-1,2-dihydropyridin-2-one 10 was synthesized by the
procedure of [6].
5-(1H-Benzimidazol-2-yl)-3-benzoyl-6-(R-amino)-2H-2-pyranones 4a,b and 5-(Benzothiazol-2-yl)-
3-benzoyl-6-(R-amino)-2H-2-pyranones 4c,d. A solution of 5-benzoyl-3-ethoxycarbonyl-6-methylthio-1-R-
880